1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: CURC - FIT-0002, NCT01512472
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000701128, RTOG-0924, NCT01368588
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S1014, S1014, NCT01309672
|
|
4.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0378, NCT01377389
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: H11-08172, NCT01446991
|
|
6.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 000008, NCT01491971
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: BCCA_Deg01, NCT01630967
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: DEG_PRE-OP_001, Degarelix Pre-Op, NCT01674270
|
|
9.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS39, NCT01234350
|
|
10.
|
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CMX-DELAY2010, NCT01366053
|
|
11.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-182, NCT01542021
|
Mobile | Español
